With over $2.9B assets under management, Frazier Healthcare Partners is a leading provider of growth capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.
James Topper Included in 2016 Midas List
Frazier Healthcare Partners Closes on New $525 Million Growth Buyout Fund
Partners Group to acquire PCI Pharma Services, a leading global provider of outsourced pharmaceutical services
FDA Approves Qbrelis™, the First and Only Lisinopril Oral Solution 1 mg/mL for Pediatric Patients 6 Years of Age and Older